SLU-PP-332 oral or injectable The realm of innovative biochemical research continuously unveils compounds with the potential to revolutionize our understanding of human physiology and well-being. Among these, Peptide Sciences SLU-PP-332 has emerged as a focal point of significant interest, often colloquially referred to as "exercise in a pill." This synthetic compound, a potent and selective pan estrogen related receptor (ERR) agonist, is gaining traction for its remarkable ability to mimic the metabolic benefits of physical activity. At its core, SLU-PP-332 functions as a small molecule designed to activate estrogen receptor-related receptors (ERRs), which are notably orphan nuclear receptors playing a crucial role in cellular energy regulation.
At the heart of SLU-PP-332's proposed mechanism is its interaction with the ERR family, specifically ERRα, ERRβ, and ERRγ. Research indicates that SLU-PP-332 exhibits varying affinities for these receptors, with notably strong activation of ERRα. Studies frequently cite an EC50 of 98 nM for ERRα, with values of 230 nM and 430 nM reported for ERRβ and ERRγ respectively. This selective agonism is key to its purported effects, as these receptors are intrinsically linked to the regulation of cellular metabolism, energy expenditure, and mitochondrial function.
The implications of activating these pathways are far-reaching and align with many of the physiological adaptations observed after regular physical exertion. Preclinical research, primarily conducted in murine models, suggests that SLU-PP-332 administration can mimic exercise-induced benefits on whole-body metabolism. This includes a notable increase in energy expenditure and enhanced fatty acid oxidationA Synthetic ERR Agonist Alleviates Metabolic Syndrome - PMC. This means the compound could potentially encourage the body to burn more calories and utilize fat as a primary energy source, even in the absence of increased appetite or food intake, and without necessitating additional physical activity. The scientific community, including researchers like CSLU-PP-332; Purity: ≥98% ; Formulation: A solid ; Molecular Formula: C18H14N2O2 ; Molecular Weight: 290.3 ; Alternative Names: 4-hydroxy-benzoic acid, 2-(2- .... Billon, has highlighted these findings in publications that have already garnered significant citations, underscoring the importance of this research.
Furthermore, Peptide Sciences SLU-PP-332 shows promise in supporting metabolic health. It is understood to regulate fat uptake, influencing how muscles, the liver, and adipose tissue absorb and utilize lipids. This could translate into improved lipid profiles and a more efficient metabolic system作者:C Billon·2024·被引用次数:33—SLU-PP-332administration mimics exercise-induced benefits on whole-body metabolism in mice including increased energy expenditure and fatty acid oxidation.. Early investigations and scientific discussions point towards its potential to restore mitochondrial function, the powerhouses of our cells, which are vital for overall cellular energy production and efficiency. The compound's ability to act as a pan-ERR agonist/Exercise mimetic is central to these observed and hypothesized benefits.
From a scientific standpoint, SLU-PP-332 is a synthetic compound often supplied as a high-purity powder, typically 99% or greater, with a molecular weight of approximately 290.3 g/mol and a CAS number of 303760-60-3. It is available from various reputable research chemical suppliers, often presented in formulations like a lyophilized white to off-white powder within vialsSLU-PP-332; Purity: ≥98% ; Formulation: A solid ; Molecular Formula: C18H14N2O2 ; Molecular Weight: 290.3 ; Alternative Names: 4-hydroxy-benzoic acid, 2-(2- .... These specifications are crucial for researchers to ensure the integrity and reliability of experimental data.SLU-PP-332is an emerging research compound knownas “exercise in a pill,” mimicking key benefits of physical activity by enhancing metabolism, endurance, and ...
While the potential of SLU-PP-332 as an "exercise in a pill" is exciting, it is imperative to emphasize that it is currently a research compound. Its application is primarily within laboratory and preclinical research systems.作者:H Nasri·2024—SLU-PP-332is a synthetic estrogen receptor-related orphan receptor (ERR) agonist, which activates an amplified aerobic exercise mode. This ... The scientific investigation into its effects, including on metabolic syndrome, continues to evolve. The results observed in mice, such as increased energy expenditure and fatty acid oxidation, are promising indicators but require further rigorous study to ascertain their applicability and safety in human subjectsView of SLU-PP-332 AND RELATED ERRα AGONISTS.
In summary, Peptide Sciences SLU-PP-332 represents a significant area of ongoing scientific inquiry. Its mechanism as a pan-agonist of the estrogen receptor-related receptors (ERRs), particularly ERRα, positions it as a fascinating tool for exploring metabolic regulation and mimicking the benefits of exercise. While its colloquial title of "exercise in a pill" captures the imagination, and its potential to support metabolic health and endurance is compelling, continued rigorous scientific research is essential to fully understand its capabilities and future applications. The exploration of SLU-PP-332 underscores the dynamic nature of peptide and small molecule research in advancing our knowledge of biological processes作者:H Nasri·2024—SLU-PP-332is a synthetic estrogen receptor-related orphan receptor (ERR) agonist, which activates an amplified aerobic exercise mode. This ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.